Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The optimal cut-off value in fit-based colorectal cancer screening: An observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Impact of chronic diseases on effect of breast cancer screening

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Cancer-related psychological distress may lead to depression and anxiety among survivors. The vast majority of patients with Hodgkin lymphoma (HL) become long-term survivors, but the risk of mental health problems after HL is not well-characterized. Using national population-based registries, we investigated the cumulative incidence of psychotropic drug (antidepressants, antipsychotics, and anxiolytics) use (proxies for depression and anxiety) in HL patients as well as if an increased risk would normalize over time for patients in remission. The study included 945 HL patients aged 18-92 years and 4725 matched persons. In total, 215 HL patients (22.8%) received a prescription of any psychotropic drug (PD) at some point after date of diagnosis compared to 545 persons (11.5%) in the matched cohort. Cumulative incidences with death/relapse as competing risk confirmed that HL patients were at higher risk of receiving psychotropic drug prescriptions, but the increased risk was transient and normalized to the matched population 5 years into survivorship. Increased age, Eastern Cooperative Oncology Group performance status, and disease stage were associated with higher risk of psychotropic drug prescriptions. Given the increased rate of psychotropic drug prescriptions after HL diagnosis, screening for symptoms of depression and anxiety is warranted after HL diagnosis and first years into survivorship.

Original languageEnglish
JournalCancer Medicine
Volume9
Issue number12
Pages (from-to)4395-4404
Number of pages10
ISSN2045-7634
DOIs
Publication statusPublished - Jun 2020

ID: 62111896